NCT03240510Unknown不适用
Understanding Male Breast Cancer: Salah Azaïz Cancer Institute Experience
Salah Azaïz Cancer Institute1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2014年1月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 150
- 试验地点
- 1
- 主要终点
- Clinico-biological characteristics of the disease
研究概览
简要总结
The goal of this study is to evaluate the Salah Azaïz Cancer Institute male breast cancer patients population over a period of 14 years.
Goal of the retrospective part: to gather clinicopathologic data and follow-up outcomes of male breast cancer patients diagnosed and/or treated at Salah Azaïz Cancer Institute from 2004 to 2013.
Goal of the prospective part: to create a registry of male patients with breast cancer for a period of 48 months (from 2014 to 2017).
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Histological diagnosis of male breast cancer
排除标准
- 未提供
结局指标
主要结局
Clinico-biological characteristics of the disease
时间窗: Through study completion, an average of 4 year
Clinical outcomes
时间窗: Through study completion, an average of 4 year
Survival, Disease free survival
次要结局
未报告次要终点
研究者
Syrine Abdeljaoued
PhD in Oncology, Study Chair
Salah Azaïz Cancer Institute
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Male Breast Cancer Summa Health System/Akron City Hospital Experience 1995-2007Breast CancerNCT00773669Summa Health System24
进行中（未招募）
不适用
Male Breast Cancer: Understanding the Biology for Improved Patient CareBreast CancerNCT01101425European Organisation for Research and Treatment of Cancer - EORTC200
招募中
不适用
The Characteristics, Treatment Patterns and Prognosis of Chinese Male Breast Cancer: A Real-world StudyBreast CancerNCT06220630First Affiliated Hospital, Sun Yat-Sen University1,200
终止
不适用
Longitudinal Assessment of Arthralgia and Related Symptoms in Breast Cancer Patients Receiving Aromatase InhibitorsBreast CancerNCT00738998M.D. Anderson Cancer Center102
进行中（未招募）
不适用
ASSESSING THE GAY MALE EXPERIENCE WITH ANAL CANCER PREVENTION STRATEGIESAnal CancerNCT05628194University of Minnesota92